** **Microsoft and NVIDIA are partnering to revolutionize healthcare and life sciences with advanced cloud, AI, and accelerated computing technologies, aiming to accelerate innovation and improve patient care globally.**Unique Bullet Points:**- Collaboration focuses on leveraging generative AI, cloud, and accelerated computing for healthcare and life sciences.- Aims to accelerate clinical research, drug discovery, and enhance medical image-based diagnostic technology.- Partnership extends opportunities for healthcare providers, pharmaceutical companies, and medical device developers to innovate rapidly.- Faster drug discovery facilitated by NVIDIA BioNeMo on NVIDIA DGX Cloud hosted on Microsoft Azure.- Enhanced clinical research and care delivery through imaging-based AI diagnostic technology using Microsoft Azure, NVIDIA MONAI, and Nuance Precision Imaging Network.
Microsoft and NVIDIA Collaboration: Accelerating Healthcare Innovation
Microsoft and NVIDIA join forces to revolutionize healthcare and life sciences with advanced technology.
What’s New
Microsoft expands collaboration with NVIDIA to bring generative AI, cloud, and accelerated computing to healthcare.
Major Updates
The collaboration aims to accelerate clinical research, drug discovery, and enhance medical image-based diagnostic technology.
What’s Important to Know
The partnership will drive innovation in healthcare, making care more precise, accessible, and effective globally.
“The convergence of AI, cloud computing, and healthcare is set to transform patient care.” – Kimberly Powell
Microsoft and NVIDIA aim to unlock breakthroughs in healthcare to deliver a meaningful difference in patients’ lives.
Faster Drug Discovery
NVIDIA BioNeMo on NVIDIA DGX Cloud, hosted on Microsoft Azure, accelerates AI-powered drug discovery.
Enhancing Clinical Research
Imaging-based AI diagnostic technology leveraging Microsoft Azure, NVIDIA MONAI, and Nuance Precision Imaging Network.
The collaboration between Microsoft and NVIDIA will drive meaningful impact for patients worldwide.
From the Stories
